X

Handbook of Neuro-Oncology Neuroimaging

Product ID : 19313275


Galleon Product ID 19313275
Model
Manufacturer
Shipping Dimension Unknown Dimensions
I think this is wrong?
-
12,243

*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown

Pay with

About Handbook Of Neuro-Oncology Neuroimaging

Product Description Remarkable progress in neuro-oncology due to increased utilization of advanced imaging in clinical practice continues to accelerate in recent years. Refinements in magnetic resonance imaging (MRI) and computed tomography (CT) technology, and the addition of newer anatomical, functional, and metabolic imaging methods, such as MRS, fMRI, diffusion MRI, and DTI MRI have allowed brain tumor patients to be diagnosed much earlier and to be followed more carefully during treatment. With treatment approaches and the field of neuro-oncology neuroimaging changing rapidly, this second edition of the Handbook of Neuro-Oncology Neuroimaging is so relevant to those in the field, providing a single-source, comprehensive, reference handbook of the most up-to-date clinical and technical information regarding the application of neuro-Imaging techniques to brain tumor and neuro-oncology patients. This new volume will have updates on all of the material from the first edition, and in addition will feature several new important chapters covering diverse topics such as advanced imaging techniques in radiation therapy, therapeutic treatment fields, response assessment in clinical trials, surgical planning of neoplastic disease of the spine, and more. It will also serve as a resource of background information to neuroimaging researchers and basic scientists with an interest in brain tumors and neuro-oncology. Review A comprehensive handbook updating the current methods and techniques in the neuro-oncology neuroimaging field From the Back Cover Remarkable progress has taken place in neuro-oncology because of the increased utilization of advanced imaging technologies in clinical practice, and continues to accelerate in recent years. With the introduction of computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), anatomical, functional, and metabolic imaging have improved the visualization and localization of tumors, and provided target definition for various therapeutic modalities. The further refinements in MRI and CT technology, and the addition of newer imaging methods, such as MRS, fMRI, diffusion MRI, and DTI MRI have allowed brain tumor patients to be diagnosed much earlier in the course of their illness and to be followed more carefully during treatment. The first edition of the Handbook of Neuro-Oncology Neuroimaging has served as a single-source, comprehensive, reference handbook that encompassed the most up-to-date clinical and technical information regarding the application of neuro-Imaging techniques to brain tumor and neuro-oncology patients. The field of neuro-oncology neuroimaging is changing very quickly, as are the treatment approaches being used in this patient population. That is why the production of a 2nd edition seems so relevant to those in the field. This new volume will have updates on all of the material from the previous chapters from the 1st edition. In addition, several new important chapters covering diverse topics such as "Advanced Imaging Techniques in Radiation Therapy Planning for Tx of Brain Tumors", "Advanced Imaging Techniques and Planning with Therapeutic Treatment Fields", "RANO Criteria: Response Assessment in Clinical Trials", "Pseudoprogression in Neuro-Oncology: Overview, Pathophysiology, and Interpretation", and "Neuroimaging for Surgical Planning of Neoplastic Disease of the Spine" will also be featured. In addition, the book can serve as a resource of background information to neuroimaging researchers and basic scientists with an interest in brain tumors and Neuro-Oncology. About the Author Dr. Newton is currently the Director of the Neuro-Oncology Center and CNS Oncology Program at the Florida Hospital Cancer Institute and Florida Hospital Orlando. He recently retired as a Professor of Neurology, Neurosurgery, and Oncology at the Wexner Medical Center at Ohio State University and the James Cancer Hospital, and was the holder of